GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Balaxi Pharmaceuticals Ltd (NSE:BALAXI) » Definitions » Scaled Net Operating Assets

Balaxi Pharmaceuticals (NSE:BALAXI) Scaled Net Operating Assets : 0.00 (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Balaxi Pharmaceuticals Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Balaxi Pharmaceuticals's operating assets for the quarter that ended in Dec. 2023 was ₹0 Mil. Balaxi Pharmaceuticals's operating liabilities for the quarter that ended in Dec. 2023 was ₹0 Mil. Balaxi Pharmaceuticals's Total Assets for the quarter that ended in Sep. 2023 was ₹2,145 Mil. Therefore, Balaxi Pharmaceuticals's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2023 was 0.00.


Balaxi Pharmaceuticals Scaled Net Operating Assets Historical Data

The historical data trend for Balaxi Pharmaceuticals's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Balaxi Pharmaceuticals Scaled Net Operating Assets Chart

Balaxi Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only 2.01 3.89 1.86 1.10 0.95

Balaxi Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Balaxi Pharmaceuticals's Scaled Net Operating Assets

For the Biotechnology subindustry, Balaxi Pharmaceuticals's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Balaxi Pharmaceuticals's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Balaxi Pharmaceuticals's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Balaxi Pharmaceuticals's Scaled Net Operating Assets falls into.



Balaxi Pharmaceuticals Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Balaxi Pharmaceuticals's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Mar. 2023 )
=(Operating Assets (A: Mar. 2023 )-Operating Liabilities (A: Mar. 2023 ))/Total Assets (A: Mar. 2022 )
=(2114.522-434.827)/1764.706
=0.95

where

Operating Assets(A: Mar. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=2396.69 - 282.168
=2114.522

Operating Liabilities(A: Mar. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=567.892 - 25.555 - 107.51
=434.827

Balaxi Pharmaceuticals's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2023 )
=(Operating Assets (Q: Dec. 2023 )-Operating Liabilities (Q: Dec. 2023 ))/Total Assets (Q: Sep. 2023 )
=(0-0)/2144.718
=0.00

where

Operating Assets(Q: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0 - 0
=0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Balaxi Pharmaceuticals Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Balaxi Pharmaceuticals's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Balaxi Pharmaceuticals (NSE:BALAXI) Business Description

Traded in Other Exchanges
N/A
Address
Phase-III, Road No: 81, Jubilee Hills, Plot No.409, H,No: 8-2-293, MAPS Towers, 2nd Floor, Hyderabad, TG, IND, 500 096
Balaxi Pharmaceuticals Ltd is an Indian branded IPR-based pharmaceutical company focusing on frontier markets, with a vast and growing portfolio of prescription and OTC drugs, across multiple therapeutic segments. Substantial revenue is generated from the pharmaceutical segment division from generic drugs. Geographically it earns key revenue from Angola.

Balaxi Pharmaceuticals (NSE:BALAXI) Headlines

No Headlines